DENTSPLY SIRONA (NASDAQ:XRAY) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) posted its earnings results on Thursday. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01), Zacks reports. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock traded down $0.09 during trading hours on Thursday, hitting $12.71. 6,803,858 shares of the company were exchanged, compared to its average volume of 4,690,824. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36. DENTSPLY SIRONA has a 1 year low of $9.85 and a 1 year high of $19.03. The stock has a market capitalization of $2.54 billion, a price-to-earnings ratio of -2.88, a P/E/G ratio of 1.03 and a beta of 1.01. The business has a 50-day moving average of $12.32 and a 200-day moving average of $12.47.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.0%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.48%.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research analyst reports. Barclays began coverage on DENTSPLY SIRONA in a research note on Monday, December 8th. They set an “underweight” rating and a $12.00 price target for the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, January 21st. UBS Group decreased their target price on DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating on the stock in a research note on Tuesday, February 3rd. Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Finally, Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $14.46.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.50% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in DENTSPLY SIRONA in the 1st quarter worth approximately $26,000. Caitong International Asset Management Co. Ltd lifted its stake in DENTSPLY SIRONA by 337.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,122 shares during the last quarter. Kestra Advisory Services LLC bought a new position in DENTSPLY SIRONA in the 4th quarter valued at about $56,000. Persistent Asset Partners Ltd acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth about $98,000. Finally, Compound Planning Inc. bought a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $117,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.